MedPage Today on MSN1d
Rapid Improvement in Atopic Dermatitis With Dual JAK/TYK2 Inhibitor
More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 weeks of ...
MedPage Today on MSN4d
T-Cell Rebalancing Therapy Active in Previously Treated Atopic Dermatitis
A novel therapy for atopic dermatitis (AD) led to at least 75% improvement in a third of patients after 6 months, a ...
The American Journal of Managed Care22h
Atopic Dermatitis Treatment Strategies Using Ruxolitinib, Considering Crucial Role of Skin Microbiome
Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...